Cost effectiveness of shortening screening interval or extending age range of NHS breast screening programme: Computer simulation study

British Medical Journal

Volumn 317, Issue 7155, 1998, Pages 376-379

  Boer, Rob ^a   De Koning, Harry ^a   Threlfall, Anthony ^b   Warmerdam, Peter ^a   Street, Andrew ^c   Friedman, Ellis ^d   Woodman, Ciaran ^b  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c UNIVERSITY OF YORK   (United Kingdom)

^d West Pennine Health Authority   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; ARTICLE; BREAST CANCER; CANCER SCREENING; COMPARATIVE STUDY; COMPUTER SIMULATION; COST EFFECTIVENESS ANALYSIS; FEMALE; HEALTH CARE COST; HUMAN; LIFESPAN; LITERATURE; PRIORITY JOURNAL; UNITED KINGDOM;

EID: 0032497093     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.317.7155.376     Document Type: Article

References (11)

1. Forrest APM. Report to the health ministers of England, Wales, Scotland and Northern Ireland by a working group chaired by Sir Patrick Forrest. London: HMSO, 1987.
2. van Oortmarssen GJ, Habbema JD, van der Maas PJ, de Koning HJ. Collette HJ, Verbeek AL, et al. A model for breast cancer screening. Cancer 1990;66:1601-12.
3. de Koning HJ, Boer R, Warmerdam PG, Beemsterboer PM, van der Maas PJ. Quantitative interpretation of age-specific mortality reductions from the Swedish breast cancer-screening trials. J Natl Cancer Inst 1995;87:1217-23.
4. Chamberlain J, Moss SM, Kirkpatrick AE, Michell M, Johns L. NHS breast screening programme results for 1991-2 [published correction appears in BMJ 1993;307:543]. BMJ 1993;307:353-6.
5. Street AD, Posnett J, Threlfall AG, Woodman CBJ, Twelves E, Friedman EHI, et al. Economic evaluation of proposed changes to the breast screening programme. York: York Health Economics Consortium, University of York, 1996. (Report P20/03.)
6. Scottish Cancer Therapy Network. Scottish breast cancer audit 1987 and 1993. Report to the chief scientist and CRAG. Edinburgh: Scottish Cancer Therapy Network, 1996.
7. Brown ML, Fintor L. Cost-effectiveness of breast cancer screening: preliminary results of a systematic review of the literature, Breast Cancer Res Treat 1993;25:113-8.
8. de Koning HJ, van Ineveld BM, van Oortmarssen GJ, de Haes JC, Collette HJ, Hendriks JH, et al. Breast cancer screening and cost-effectiveness; policy alternatives, quality of life considerations and the possible impact of uncertain factors. Int J Cancer 1991;49:531-7.
9. van Ineveld BM, van Oortmarssen GJ, de Koning HJ, Boer R, van der Maas PJ. How cost-effective is breast cancer screening in different EC countries? Eur J Cancer 1993;12:1663-8.
10. Beemsterboer PM, de Koning HJ, Warmerdam PG, Boer R, Swart E, Dierks ML, et al. Prediction of the effects and costs of breast-cancer screening in Germany. Int J Cancer 1994;58:623-8.
11. Paci E, Boer R, Zappa M, de Koning HJ, van Oortmarssen GJ, Crocetti E, et al. A model-based prediction of the impact on reduction in mortality by a breast cancer screening programme in the city of Florence. Italy. Eur J Cancer 1995;3:348-53.